University of Florida Innovators Honored at 4th Annual Standing InnOvation Event
On a sunny and fresh fall afternoon, UF Innovate | Tech Licensing hosted its annual event to recognize top innovations stemming out of the University of Florida. More than 150 innovators and entrepreneurs attended the in-person event, and around 40 joined the livestream to celebrate their achievements in fiscal year 2021.
Resilience Turns to Harvard for Biologics Manufacturing Tech, Inks 5-Year R&D Pact
Resilience, a company developing technologies that overcome the challenges of manufacturing complex biological medicines, is turning to Harvard University to find some of those new solutions.
Here’s How Seasonal Affective Disorder Can Make Sleep Worse—And What You Can Try, According to a Therapist
Sherry Benton, founder of TAO Connect, a UF Innovate | Accelerate startup, shares why seasonal affective disorder occurs and ways to overcome it.
How This 23-Year-Old’s Startup Became The Fastest-Growing Company in a $25B Industry
With year-over-year growth of 762.3%, UF Innovate | Accelerate graduate Imprint Genius, a company providing high-quality, unique promotional products, takes the number one position for “Fastest Growing Distributors” in 2020, as published in Print+Promo Marketing Magazine.
Rain Neuromorphics Tapes Out Demo Chip for Analog AI
UF startup and UF Innovate | Accelerate graduate Rain Neuromorphics, which incubated at The Hub, has taped out a demonstration chip for its brain-inspired analog architecture that employs a 3D array of randomly-connected memristors to compute neural network training and inference at extremely low power.
AavantiBio Furthers Strategic Partnership With University of Florida To Research and Develop Next Generation Gene Therapy Capsids
UF startup and UF Innovate | The Hub resident AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, announced it is partnering with the University of Florida to research and develop next generation gene therapy capsids with the goal of creating safer, more effective, and tissue specific gene therapies.
